Drug intelligence / Profile preview

Oleander 4X

Development stage
Unknown
Lead developer
Phoenix Biotechnology
Administration
Oral
01

Overview

Oleander 4X (also known as Oleander 4X HPUS) is a homeopathic tincture developed by Avila Herbals in partnership with Phoenix Biotechnology. The product is derived from a botanical extract of *Nerium oleander* leaves and is formulated as a 4X dilution (1:10,000) in a 20% alcohol solution. It is indicated for the temporary relief of symptoms associated with influenza, the common cold, and respiratory distress, including fever, muscle aches, headaches, chills, cough, and congestion. As a homeopathic preparation, it does not target specific biological pathways in a conventional pharmaceutical manner but is instead based on the principle of 'like cures like.' A Phase I randomized, double-blind, placebo-controlled clinical trial has been conducted to evaluate the safety and pharmacokinetics of the formulation in healthy volunteers.

Brand names
Oleander 4XOleander4XOleander-4XOleander 4X, Incubation
Other names
Oleander 4X HPUSOleander4X HPUSOleander-4X HPUS
02

Targets

FOS (Activator Protein 1)JUN (Transcription factor Jun)NF-κB

Beyond the preview

Go deeper on Oleander 4X.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oleander 4X.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call